FDA acknowledges estrogen patch shortage, says it’s working to increase supply

By: Kelcie Moseley-Morris

Outlets: Stateline

Published: September 16, 2026

Words: 334

Last Updated: 20 hours, 33 minutes ago


Body Text Preview

The U.S. Food and Drug Administration says it’s helping manufacturers increase the supply of estrogen-based hormonal patches and acknowledged a current nationwide shortage as more women seek hormonal therapies for symptoms related to menopause.

In a release earlier this month, the FDA said it is expediting actions to increase supply, and said all six manufacturers are working to expand capacity and prioritize production of the patches.

Shifting attitudes on menopause drive lawmakers to push …